929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

lutropin alfa 75 units injection [10 vials] (&) inert substance diluent [10 x 1 mL ampoules], 1 pack

vecuronium bromide 4 mg injection [10 ampoules] (&) inert substance diluent [10 x 1 mL ampoules], 1 pack

susoctocog alfa 500 units injection [10 vials] (&) inert substance diluent [10 x 1 mL syringes], 1 pack

lutropin alfa 75 units injection [10 vials] (&) inert substance diluent [10 x 1 mL vials], 1 pack

octocog alfa 1000 units injection [10 vials] (&) inert substance diluent [10 x 2.5 mL syringes], 1 pack

octocog alfa 250 units injection [10 vials] (&) inert substance diluent [10 x 2.5 mL syringes], 1 pack

octocog alfa 500 units injection [10 vials] (&) inert substance diluent [10 x 2.5 mL syringes], 1 pack

somatropin 3 mg injection [10 vials] (&) inert substance diluent [10 x 5 mL vials], 1 pack

interferon beta-1b 8 million units (250 microgram) injection [15 vials] (&) inert substance diluent [15 x 1.2 mL syringes], 1 pack

interferon beta-1b 8 million units (250 microgram) injection [15 vials] (&) inert substance diluent [15 x 2 mL vials], 1 pack

voretigene neparvovec 5 trillion vector genomes/mL injection [0.5 mL vial] (&) inert substance diluent [2 x 1.7 mL vials], 1 pack

pamidronate disodium 30 mg injection [2 vials] (&) inert substance diluent [2 x 10 mL ampoules], 1 pack

reteplase 10 units (17.4 mg) injection [2 x 10 unit vials] (&) inert substance diluent [2 x 10 mL syringes], 1 pack

teduglutide 5 mg injection [28 vials] (&) inert substance diluent [28 x 0.5 mL syringes], 1 pack

lutropin alfa 75 units injection [3 vials] (&) inert substance diluent [3 x 1 mL ampoules], 1 pack

rasburicase 1.5 mg injection [3 vials] (&) inert substance diluent [3 x 1 mL ampoules], 1 pack

Japanese encephalitis (mouse brain-derived) inactivated vaccine injection [3 vials] (&) inert substance diluent [3 x 1 mL vials], 1 pack

lutropin alfa 75 units injection [3 vials] (&) inert substance diluent [3 x 1 mL vials], 1 pack

parecoxib 40 mg injection [3 vials] (&) inert substance diluent [3 x 2 mL ampoules], 1 pack

pegvisomant 10 mg injection [30 vials] (&) inert substance diluent [30 syringes], 1 pack

pegvisomant 15 mg injection [30 vials] (&) inert substance diluent [30 syringes], 1 pack

pegvisomant 20 mg injection [30 vials] (&) inert substance diluent [30 syringes], 1 pack

pegvisomant 10 mg injection [30 vials] (&) inert substance diluent [30 vials], 1 pack

pegvisomant 15 mg injection [30 vials] (&) inert substance diluent [30 vials], 1 pack

pegvisomant 20 mg injection [30 vials] (&) inert substance diluent [30 vials], 1 pack

interferon beta-1a 6 million units (30 microgram) injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack

interferon beta-1a 6 million units (30 microgram) injection [4 vials] (&) inert substance diluent [4 x 1.1 mL syringes], 1 pack

interferon beta-1a 12 million units (60 microgram) injection [4 vials] (&) inert substance diluent [4 x 1.1 mL syringes], 1 pack

pamidronate disodium 15 mg injection [4 vials] (&) inert substance diluent [4 x 5 mL ampoules], 1 pack

rotavirus live vaccine powder for oral liquid [5 vials] (&) inert substance diluent [5 syringes], 1 pack

meningococcal C conjugate vaccine injection [5 vials] (&) inert substance diluent [5 x 0.5 mL syringes], 1 pack

measles 1000 TCID50 units + mumps 12 500 TCID50 units + rubella 1000 TCID50 units injection [5 vials] (&) inert substance [5 x 0.7 mL vials], 1 pack

rabies vaccine injection [5 vials] (&) inert substance diluent [5 x 1 mL ampoules], 1 pack

susoctocog alfa 500 units injection [5 vials] (&) inert substance diluent [5 x 1 mL syringes], 1 pack

somatropin 8 mg injection [5 vials] (&) inert substance diluent [5 x 1.37 mL cartridges], 1 pack

parecoxib 40 mg injection [5 vials] (&) inert substance diluent [5 x 2 mL ampoules], 1 pack

methylprednisolone 500 mg injection [5 vials] (&) inert substance diluent [5 x 8 mL vials], 1 pack

smallpox live vaccine injection [50 vials] (&) inert substance diluent [50 x 0.6 mL vials], 1 pack

vecuronium bromide 4 mg injection [50 ampoules] (&) inert substance diluent [50 x 1 mL ampoules], 1 pack

somatropin 5 mg injection [8 vials] (&) inert substance diluent [8 x 1.14 mL cartridges], 1 pack

norethisterone 1 mg + mestranol 50 microgram tablet [21] (&) inert substance tablet [7], 28

norethisterone 1 mg + mestranol 50 microgram tablet [21] (&) inert substance tablet [7], 4 x 28

infliximab 100 mg injection, 1 vial

infliximab 120 mg/mL injection, 1 mL pen device

infliximab 120 mg/mL injection, 1 mL syringe

infliximab 120 mg/mL injection, 2 x 1 mL pen devices

infliximab 120 mg/mL injection, 2 x 1 mL syringes

infliximab 120 mg/mL injection, 4 x 1 mL pen devices

infliximab 120 mg/mL injection, 4 x 1 mL syringes

infliximab 120 mg/mL injection, 6 x 1 mL pen devices

infliximab 120 mg/mL injection, 6 x 1 mL syringes

ingenol mebutate 0.015% gel, 3 x 470 mg

ingenol mebutate 0.015% gel, 470 mg

ingenol mebutate 0.05% gel, 2 x 470 mg

ingenol mebutate 0.05% gel, 470 mg

inotuzumab ozogamicin 1 mg injection, 1 vial

insulin aspart 100 units/mL injection, 1 x 10 mL vial

insulin aspart 100 units/mL injection, 3 mL pen device

insulin aspart 100 units/mL injection, 10 x 3 mL cartridges

insulin aspart 100 units/mL injection, 10 x 3 mL pen devices

insulin aspart 100 units/mL injection, 5 x 10 mL vials

insulin aspart 100 units/mL injection, 5 x 3 mL cartridges

insulin aspart 100 units/mL injection, 5 x 3 mL pen devices

insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL cartridges

insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL pen devices

insulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 3 mL pen device

insulin aspart 30 international units / 1 mL + insulin degludec 70 international units / 1 mL injection, 5 x 3 mL cartridges (medicinal product pack)

insulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 5 x 3 mL pen devices

insulin aspart 50 units/mL + insulin aspart protamine 50 units/mL injection, 5 x 3 mL cartridges

insulin aspart 50 units/mL + insulin aspart protamine 50 units/mL injection, 5 x 3 mL pen devices

insulin aspart 70 units/mL + insulin aspart protamine 30 units/mL injection, 5 x 3 mL cartridges

insulin aspart 70 units/mL + insulin aspart protamine 30 units/mL injection, 5 x 3 mL pen devices

insulin degludec 100 units/mL + liraglutide 3.6 mg/mL injection, 3 mL pen device

insulin degludec 100 units/mL + liraglutide 3.6 mg/mL injection, 3 x 3 mL pen devices

insulin degludec 100 units/mL + liraglutide 3.6 mg/mL injection, 5 x 3 mL pen devices

insulin degludec 100 units/mL injection, 3 mL pen device

insulin degludec 100 units/mL injection, 5 x 3 mL cartridges

insulin degludec 100 units/mL injection, 5 x 3 mL pen devices

insulin degludec 200 units/mL injection, 3 mL pen device

insulin degludec 200 units/mL injection, 3 x 3 mL pen devices

insulin detemir 100 units/mL injection, 5 x 3 mL cartridges

insulin detemir 100 units/mL injection, 5 x 3 mL pen devices

insulin glargine 100 units/mL + lixisenatide 33 microgram/mL injection, 3 mL pen device

insulin glargine 100 units/mL + lixisenatide 33 microgram/mL injection, 3 x 3 mL pen devices

insulin glargine 100 units/mL + lixisenatide 33 microgram/mL injection, 5 x 3 mL pen devices

insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 mL pen device

insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 x 3 mL pen devices

insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 5 x 3 mL pen devices

insulin glargine 100 units/mL injection, 1 x 10 mL vial

insulin glargine 100 units/mL injection, 3 mL cartridge

insulin glargine 100 units/mL injection, 3 mL pen device

insulin glargine 100 units/mL injection, 10 x 3 mL cartridges

insulin glargine 100 units/mL injection, 10 x 3 mL pen devices

insulin glargine 100 units/mL injection, 2 x 3 mL cartridges

insulin glargine 100 units/mL injection, 2 x 3 mL pen devices

insulin glargine 100 units/mL injection, 5 x 3 mL cartridges

insulin glargine 100 units/mL injection, 5 x 3 mL pen devices

insulin glargine 300 units/mL injection, 1.5 mL pen device

insulin glargine 300 units/mL injection, 3 mL pen device

insulin glargine 300 units/mL injection, 3 x 1.5 mL pen devices

insulin glargine 300 units/mL injection, 3 x 3 mL pen devices

Start Previous Page 93 of 160 Next End

Reference Sets

Reference set descriptor